﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>03</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>A novel imidazo[1,2-a]pyridine derivative and its co-administration with curcumin exert anti-inflammatory effects by modulating the STAT3/NF-κB/iNOS/COX-2 signaling pathway in breast and ovarian cancer cell lines</ArticleTitle>
    <FirstPage>27618</FirstPage>
    <LastPage>27618</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.2023.27618</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Havva</FirstName>
        <LastName>Afshari</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-2118-0373</Identifier>
      </Author>
      <Author>
        <FirstName>Shokoofe</FirstName>
        <LastName>Noori</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3889-392X</Identifier>
      </Author>
      <Author>
        <FirstName>Mitra</FirstName>
        <LastName>Nourbakhsh</LastName>
      </Author>
      <Author>
        <FirstName>Azam</FirstName>
        <LastName>Daraei</LastName>
      </Author>
      <Author>
        <FirstName>Mahsa</FirstName>
        <LastName>Azami Movahed</LastName>
      </Author>
      <Author>
        <FirstName>Afshin</FirstName>
        <LastName>Zarghi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.2023.27618</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>09</Month>
        <Day>22</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Imidazo[1,2-a]pyridine derivatives with diverse pharmacological properties and curcumin, as a potential natural anti-inflammatory compound, are promising compounds for cancer treatment. This study aimed to synthesize a novel imidazo[1,2-a]pyridine derivative, (MIA), and evaluate its anti-inflammatory activity and effects on nuclear factor-κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3) pathways, and their target genes, alone and in combination with curcumin, in MDA-MB-231 and SKOV3 cell lines. Methods: We evaluated the interaction between imidazo[1,2-a]pyridine ligand, curcumin, and NF-κB p50 protein, using molecular docking studies. MTT assay was used to investigate the impacts of compounds on cell viability. To evaluate the NF-κB DNA binding activity and the level of inflammatory cytokines in response to the compounds, ELISA-based methods were performed. In addition, quantitative polymerase chain reaction (qPCR) and western blotting were carried out to analyze the expression of genes and investigate NF-κB and STAT3 signaling pathways.  Results: Molecular docking studies showed that MIA docked into the NF-κB p50 subunit, and curcumin augmented its binding. The MTT assay results indicated that MIA and its combination with curcumin reduced cell viability. According to the results of the ELISA-based methods, MIA lowered the levels of inflammatory cytokines and suppressed NF-κB activity. In addition, real-time PCR and Griess test results showed that the expression of cyclooxygenase-2 (COX-2) and inducible NO synthase (iNOS) genes, and nitrite production were reduced by MIA. Furthermore, the western blotting analysis demonstrated that MIA increased the expression of inhibitory κB (IκBα) and B-cell lymphoma 2 (Bcl-2)-associated X proteins (BAX), and suppressed the STAT3 phosphorylation, and Bcl-2 expression. Our findings revealed that curcumin had a potentiating role and enhanced all the anti-inflammatory effects of MIA.  Conclusion: This study indicated that the anti-inflammatory activity of MIA is exerted by suppressing the NF-κB and STAT3 signaling pathways in MDA-MB-231 and SKOV3 cancer cell lines.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Imidazo[1</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">2-a]pyridine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Curcumin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">NF-κB</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Breast cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Inflammation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ovarian cancer</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>